Company intelligence / Profile preview
Pangea Pharmaceuticals
- Ownership
- Private
- Employees
- ~6
- Development stage
- Commercial
Overview
Pangea Pharmaceuticals is a US-based specialty pharmaceutical company focused on improving patient access to high-quality branded and generic medicines across several therapeutic areas. The company emphasizes affordability, safety, and rapid go-to-market strategies. It maintains a robust commercial portfolio while evaluating new product opportunities for future growth.
- Therapeutic areas
- OtherOphthalmologyNeurology
- Modalities
- Small molecules (branded and generic drugs; specific modalities not detailed)
- Industry
- Biotech
Drug pipeline
17 assets16 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Pangea Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pangea Pharmaceuticals.